Evidence map›Paper›PMID 36246788›Full record

ArticleScientometrics2023

COVID-19 and the scientific publishing system: growth, open access and scientific fields.

Gabriela F Nane, Nicolas Robinson-Garcia, François van Schalkwyk, Daniel Torres-Salinas

Open access · hybridAbstract read
In one paragraph

Article in Scientometrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. The long COVID research literature.Frontiers in research metrics and analytics · 2023
    Pooled it
  3. Article
  4. Paying peer reviewers: benefits, risks, and challenges.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Gabriela F NaneDelft Institute of Applied Mathematics (DIAM), Delft University of Technology, Delft, Netherlands.ORCID 0000-0002-3614-1820
Nicolas Robinson-GarciaEC3 Research Group, Information and Communication Studies Department, University of Granada, Granada, Spain.ORCID 0000-0002-0585-7359
François van SchalkwykDST-NRF Centre of Excellence in Scientometrics and Science, Technology and Innovation Policy, Centre for Research on Evaluation, Science and Technology, Stellenbosch University, Stellenbosch, South Africa.ORCID 0000-0002-1048-0429
Daniel Torres-SalinasEC3 Research Group, Information and Communication Studies Department, University of Granada, Granada, Spain.ORCID 0000-0001-8790-3314
Universidad de Granada · ESDelft University of Technology · NLStellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We model the growth of scientific literature related to COVID-19 and forecast the expected growth from 1 June 2021. Considering the significant scientific and financial efforts made by the research community to find solutions to end the COVID-19 pandemic, an unprecedented volume of scientific outputs is being produced. This questions the capacity of scientists, politicians and citizens to maintain infrastructure, digest content and take scientifically informed decisions. A crucial aspect is to make predictions to prepare for such a large corpus of scientific literature. Here we base our predictions on the Autoregressive Integrated Moving Average (ARIMA) and exponential smoothing models using the Dimensions database. This source has the particularity of including in the metadata information on the date in which papers were indexed. We present global predictions, plus predictions in three specific settings: by type of access (Open Access), by domain-specific repository (SSRN and MedRxiv) and by several research fields. We conclude by discussing our findings. Supplementary Information: The online version contains supplementary material available at 10.1007/s11192-022-04536-x.

Indexed as

COVID-19DimensionsGrowth of scienceOpen accessScientific publications

Identifiers

PMID36246788
PMCPMC9548429
OpenAlexW4304145091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.